ACHN
Achillion Pharmaceuticals, Inc.
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
140 hedge funds and large institutions have $411M invested in Achillion Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 60 increasing their positions, 35 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
140
Holders Change
-22
Holders Change %
-13.58%
% of All Funds
3.51%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
18
Increased
60
Reduced
35
Closed
39
Calls
$6.56M
Puts
$1.56M
Net Calls
+$5M
Net Calls Change
-$3.6M
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$10M |
| 2 |
Morgan Stanley
New York
|
+$8.37M |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$7.57M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$6.61M |
| 5 |
State Street
Boston,
Massachusetts
|
+$6.05M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$57.1M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$12.1M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$8.15M |
| 4 |
RI
RTW Investments
New York
|
-$7.94M |
| 5 |
PA
Perceptive Advisors
New York
|
-$7.53M |
